Saccharolactone
Based on 1 publication(s) in Google Scholar
Saccharolactone is a potent orally active β-glucuronidase inhibitor. Saccharolactone markedly lowers biliary endogenous β-glucuronidase activity in the rat bile. Saccharolactone can stabilize glucuronide metabolites in vitro. Saccharolactone is also a strong inhibitor of CYP1A2, 2D6, 3A4 and 2C8 isoforms (IC50 < 4 mM).
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 389-36-6
- Fòrmula: C6H8O7
- Peso molecular:192.12
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) Saccharolactone
More
Actividad biológica
|
CYP1A2 <4 mM (IC50) |
CYP2D6 <4 mM (IC50) |
CYP3A4 <4 mM (IC50) |
CYP2C8 <4 mM (IC50) |
Chemical Information
-
No. CAS 389-36-6
-
Peso molecular 192.12
-
Fòrmula C6H8O7
-
SMILES
OC([C@H]([C@]1([H])[C@@H]([C@H](C(O1)=O)O)O)O)=O
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
-
J Enzyme Inhib Med Chem
Design, synthesis, and biological evaluation of (thio)urea derivatives as potent Escherichia coli β-glucuronidase inhibitors. [Abstract]2024 Dec;39(1):2387415. PMID: 39140677
Pureza y Documentación
Referencias
[1]. Macfadyen A, et al. D-glucaro-1,4-lactone: its excretion in the bile and urine and effect on the biliary secretion of beta-glucuronidase after oral administration in rats. Hepatology. 1989 Apr;9(4):552-6. [Content Brief]
[2]. Behera D, et al. Effect of Saccharolactone on CYP-mediated Metabolism of Xenobiotics. Drug Metab Bioanal Lett. 2023;16(2):121-132. [Content Brief]
[3]. Oleson L, et al. Effect of the beta-glucuronidase inhibitor saccharolactone on glucuronidation by human tissue microsomes and recombinant UDP-glucuronosyltransferases. J Pharm Pharmacol. 2008 Sep;60(9):1175-82. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Saccharolactone Related Classifications
HY-153875 Related Classifications
Powered by Bioz